Usana Health Sciences
USNA
189 hedge funds and large institutions have $1.48B invested in Usana Health Sciences in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 68 increasing their positions, 50 reducing their positions, and 22 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
109% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 22
42% more capital invested
Capital invested by funds: $1.04B → $1.48B (+$438M)
36% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 50
13% more funds holding
Funds holding: 168 → 189 (+21)
2.81% more ownership
Funds ownership: 50.18% → 52.99% (+2.8%)
45% less call options, than puts
Call options by funds: $899K | Put options by funds: $1.64M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$51.9M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$25.5M |
| 3 |
Renaissance Technologies
New York
|
+$15.8M |
| 4 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$14.9M |
| 5 |
BlackRock
New York
|
+$14.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$80.7M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$21.3M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$13.1M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$11.6M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$7.8M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JG
201
Jefferies Group
New York
| – | -$625K | -7,271 | Closed |
|
|
VF
202
Virtu Financial
New York
| – | -$500K | -5,819 | Closed |
|
|
KI
203
Koch Industries
Wichita,
Kansas
| – | -$324K | -3,773 | Closed |
|
|
HP
204
Hikari Power
Tokyo,
Japan
| – | -$295K | -3,440 | Closed |
|
|
SFI
205
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| – | -$206K | -2,400 | Closed |
|
|
RS
206
Robeco Schweiz
Zurich,
Switzerland
| – | -$126K | -1,466 | Closed |
|
|
VCM
207
Virtue Capital Management
Brentwood,
Tennessee
| – | -$38K | -400 | Closed |
|
208
Parallax Volatility Advisers
San Francisco,
California
| – | -$27K | -310 | Closed |
|
|
SWP
209
Stratos Wealth Partners
Beachwood,
Ohio
| – | -$9K | -100 | Closed |
|
|
DA
210
Denali Advisors
San Diego,
California
| – | -$5K | -55 | Closed |
|
|
CF
211
Centaurus Financial
Anaheim,
California
| – | +$328 | +3 | New |
|
USNA Hedge Fund Activity: Q2 2018 in Review
189 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2018, worth a combined $1.48B — up 42% from $1.04B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new USNA positions and 22 closed out — a net gain of 24 holders — while 68 added to existing stakes and 50 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $51.9M. The largest seller was Fidelity Investments, cutting an estimated $80.7M.
- 189 institutional investors held Usana Health Sciences (USNA) as of Q2 2018, up from 168 in Q1 2018.
- Funds reported $1.48B of Usana Health Sciences stock for Q2 2018, up 42% quarter-over-quarter.
- 46 funds opened new Usana Health Sciences positions in Q2 2018 and 22 closed out, a net change of +24 holders.
- The largest Usana Health Sciences buyer in Q2 2018 was Acadian Asset Management, an estimated $51.9M added.
- The largest Usana Health Sciences seller in Q2 2018 was Fidelity Investments, an estimated $80.7M sold.
Based on aggregated 13F filings for Q2 2018.